Invivyd Reports Positive Phase 3 LIBERTY Results for VYD2311 and Plans Accelerated Approval Submission
Phase 3positiveVYD2311Positive
AI Analysis
Summary
Invivyd reported positive Phase 3 LIBERTY trial results for VYD2311 and announced plans to pursue accelerated approval submission for the therapy.
Clinical Trial Data
Phase
Phase 3
Primary Endpoint
Met
Outcome Details
Positive Phase 3 LIBERTY results
Importance:8/10
Sentiment:
0.80
Phase 3 dataaccelerated approvalVYD2311clinical trial
Related Companies
Read the original article
Published by yahoo_finance on September 29, 2026 2:40 PM